A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with Diabetes compared with idiopathic epiretinal membranes in nondiabetic patients

Retina

Volumn 30, Issue 9, 2010, Pages 1472-1478

  Lim, Jennifer I ^a   Spee, Christine ^a   Hinton, David R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

epiretinal membranes; hypoxic inducible factor; ischemia; proliferative diabetic retinopathy

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; VITRECTOMY;

ACTINS; ADULT; AGED; ANIMALS; ANTIGENS, CD31; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KERATINS; MALE; MEMBRANES; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RABBITS; RETINAL NEOVASCULARIZATION; STAINING AND LABELING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY;

EID: 78049232810     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181d6df09     Document Type: Article

References (20)

1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
2. Adamis AP, Altaweel M, Bressler NM, et al. Macugen Diabetic Retinopathy Study Group. Changes in retinal neovasculariza-tion after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113:23-28. (Pubitemid 43021723)
3. Vinores SA, Youssri Al, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol His-topathol 1997;12:99-109. (Pubitemid 27106924)
4. Hinton DR, Spee C, He S, et al. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 2004;27:758-764. (Pubitemid 38280546)
5. Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005;37:535-540. (Pubitemid 40022930)
6. Hewitson KS, Schofield CJ. The HIF pathway as a therapeutic agent. Drug Discov Today 2004;9:704-711.
7. Mazure NM, Brahimi-Horn MC, Berta MA, et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004;68:971-980.
8. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677-684. (Pubitemid 36749216)
9. Treins C, Giorgetti-Peraldi S, Murdaca J, Monthouel-Kartmann MN, Van Obberghen E. Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol Endocrinol 2005;19:1304-1317. (Pubitemid 40594126)
10. Armstrong D, Augustin AJ, Spengler R, et al. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retino-pathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998;212:410-414. (Pubitemid 28446600)
11. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70:1469-1480.
12. Lukiw WJ, Ottlecz A, Lambrou G, et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 2003;44:4163-4170. (Pubitemid 37186247)
13. Gao W, Ferguson G, Connell P, et al. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth vie HIF-1 alpha-dependent pathway. J Mol Cell Cardiol 2007;42:609-619. (Pubitemid 46349124)
14. Mabjeesh NJ, Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 2007;22:559-572. (Pubitemid 46647268)
15. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613. (Pubitemid 26272112)
16. Yamakawa M, Liu LX, Date T, et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003; 93:664-673. (Pubitemid 37222163)
17. Slomiany MG, Rosenzweig SA. Hypoxia-inducible factor-1-dependent and-independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 2006;318:666-675. (Pubitemid 44061241)
18. Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1 alpha and VEGF. J Clin Invest 2002;109:805-815. (Pubitemid 34263157)
19. Abu El-Asrar AM, Missotten L, Geboes K. Expression of hypoxia-inducible factor-1 alpha and the protein products of its target genes in diabetic fibrovascular epiretinal mem branes. Br J Ophthalmol 2007;91:822-826. (Pubitemid 46846660)
20. Land SC, Tee AR. Hypoxia-inducible factor-1 alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007;282:20534-20543